Related Experiment Videos
Thrombocytosis in gynecologic malignancies
1Department of Obstetrics and Gynecology, Faculty of Medicine, Trakya University, Edirne, Turkey. fgucer@yahoo.com
Anticancer Research
|July 28, 2004
Summary
Thrombocytosis, an elevated platelet count, shows prognostic value in certain gynecologic cancers. This review analyzes its impact on patient outcomes in gynecologic malignancies.
Area of Science:
- Oncology
- Hematology
Background:
- Thrombocytosis (elevated platelet count) is increasingly recognized in various cancers.
- Its prognostic significance is being investigated across different malignancy types.
Purpose of the Study:
- To review and analyze the prognostic implications of thrombocytosis in patients with gynecologic malignancies.
- To synthesize current data on the role of elevated platelet counts in predicting outcomes for these cancers.
Main Methods:
- Systematic review of published literature.
- Analysis of studies reporting thrombocytosis prevalence and outcomes in gynecologic cancers.
Main Results:
- Thrombocytosis is observed in a subset of patients with gynecologic malignancies.
- Evidence suggests thrombocytosis may serve as a prognostic indicator in specific gynecologic cancer contexts.
Conclusions:
- Thrombocytosis holds potential prognostic value in managing gynecologic malignancies.
- Further research is warranted to fully elucidate its role in patient stratification and treatment decisions.